Editors/Authors   Librarians   Newsletter   Site Tour   Subscriptions   A-Z Index   About   Contact Us   Help 
Log In | Log In via Athens
 
Disable Autosuggest
Users' Guides to the Medical Literature
Guyatt G, Rennie D, Meade MO, Cook DJ
Part B Therapy
Chapter 10.5. Measuring Patients' Experience
Toshi A. Furukawa, Roman Jaeschke, Deborah J. Cook, Gordon Guyatt
For example, in a study of methotrexate for patients with inflammatory bowel disease,39...


Topics Discussed: arthritis, rheumatoid, chronic obstructive airway disease, diabetes mellitus, health outcomes, health-related quality of life, heart failure, incorporating patient values and preferences, measuring patient experience, patient evaluation, positive and negative syndrome scale, schizophrenia, validity of evidence

Excerpt: "We have described how investigators often substitute endpoints that make intuitive sense to them for those that patients value. Clinicians can recognize these situations by asking themselves the following question: if the endpoints measured by the investigators were the only thing that changed, would patients be willing to take the treatment? In addition to changes in clinical or physiologic variables, patients would require that they feel better or live longer. For instance, if a treatment for osteoporosis increased bone density without preventing back pain, loss of height, or fractures, patients would not be interested in risking the adverse effects—or incurring the costs and inconvenience—of treatment.If, when we are trying to discriminate among people at a single point in time, everyone gets the same score, we will not be able to tell who is better and who is worse than others—in this case, who should receive therapy and who should not. The key differences we are trying to detect—the signal—come from cross-sectional differences in scores among patients. The bigger these differences are, the better off we will be...."
Log in to read the full chapter:
Subscriber Log In
Username:
Password:
Forgot your username/password?
Or  
Get full access to JAMAevidence two ways:
Subscribe to JAMAevidence
JAMAevidence is a subscription-
based website dedicated to the learning, teaching, and practicing of evidence-based medicine.
Pay Per View
Timed access to all of JAMAevidence
24 hours for $29.95
48 hours for $49.95
Copyright © American Medical Association. All rights reserved.  |  JAMA  |  The McGraw-Hill Companies, Inc.
Privacy Notice. Any use is subject to the Terms of Use and Notice. Additional Credits and Copyright Information.
Your IP address is 38.107.179.242